FGFRL1 is closely associated with the development, progression, invasion, drug resistance, and prognosis of several types of cancer, such as bladder cancer, esophageal cancer, larynx carcinoma, lung cancer, ovarian cancer, pancreatic cancer, and prostate cancer. Here, FGFRL1 is linked to ovarian carcinoma.